Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 07, 2023

SELL
$0.42 - $0.81 $18,214 - $35,127
-43,367 Reduced 98.97%
452 $0
Q4 2022

Jan 30, 2023

BUY
$1.08 - $2.35 $560 - $1,219
519 Added 1.2%
43,819 $57,000
Q3 2022

Nov 08, 2022

BUY
$0.43 - $4.31 $6,450 - $64,649
15,000 Added 53.0%
43,300 $100,000
Q2 2022

Aug 04, 2022

BUY
$2.81 - $12.91 $79,523 - $365,353
28,300 New
28,300 $96,000

Others Institutions Holding CELU

About Celularity Inc


  • Ticker CELU
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 142,424,000
  • Market Cap $319M
  • Description
  • Celularity Inc., a clinical-stage biotechnology company, develops off-the-shelf placental-derived allogeneic cell therapies for the treatment of cancer, immune, and infectious diseases. It operates through three segments: Cell Therapy, Degenerative Disease, and BioBanking. The company's lead therapeutic programs include CYCART-19, a placental-de...
More about CELU
Track This Portfolio

Track New York State Common Retirement Fund Portfolio

Follow New York State Common Retirement Fund and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of New York State Common Retirement Fund, based on Form 13F filings with the SEC.

News

Stay updated on New York State Common Retirement Fund with notifications on news.